Immunoprotection elicited by an enterovirus type 71 experimental inactivated vaccine in mice and rhesus monkeys.
about
Production of EV71 vaccine candidatesIs a multivalent hand, foot, and mouth disease vaccine feasible?Pilot scale production of highly efficacious and stable enterovirus 71 vaccine candidates.Animal models of enterovirus 71 infection: applications and limitations.Immunization of N terminus of enterovirus 71 VP4 elicits cross-protective antibody responses.A novel universal neutralizing monoclonal antibody against enterovirus 71 that targets the highly conserved "knob" region of VP3 protein.Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn miceThe immunogenicity and protection effect of the BPL-inactivated CA16 vaccine in different animal systems.Long-term immunogenicity studies of formalin-inactivated enterovirus 71 whole-virion vaccine in macaques.Comparative analysis of the immunogenicity and protective effects of inactivated EV71 vaccines in mice.Study of the integrated immune response induced by an inactivated EV71 vaccineFormalin-inactivated EV71 vaccine candidate induced cross-neutralizing antibody against subgenotypes B1, B4, B5 and C4A in adult volunteers.Immunity and clinical efficacy of an inactivated enterovirus 71 vaccine in healthy Chinese children: a report of further observations.Immunological evaluation and comparison of different EV71 vaccine candidates.A neonatal mouse model of coxsackievirus A16 for vaccine evaluationEV71 virus-like particles produced by co-expression of capsid proteins in yeast cells elicit humoral protective response against EV71 lethal challengeClinical and Associated Immunological Manifestations of HFMD Caused by Different Viral Infections in Children.Transgenic mouse model for the study of enterovirus 71 neuropathogenesis.Progress on the research and development of inactivated EV71 whole-virus vaccines.Development of a sandwich ELISA for the quantification of enterovirus 71.The molecule of DC-SIGN captures enterovirus 71 and confers dendritic cell-mediated viral trans-infection.Progress on the research and development of human enterovirus 71 (EV71) vaccines.Development of enterovirus 71 vaccines: from the lab bench to Phase III clinical trials.Update on the development of enterovirus 71 vaccines.Enterovirus 71: a whole virion inactivated enterovirus 71 vaccine.Cost-effectiveness of a national enterovirus 71 vaccination program in China.Phase 3 Trial of a Sabin Strain-Based Inactivated Poliovirus Vaccine.A neonatal gnotobiotic pig model of human enterovirus 71 infection and associated immune responses.The immune mechanism of intestinal tract Toll-like receptor in mediating EV71 virus type severe hand-foot-and-mouth disease and the MAPK pathway.Immune responses to baculovirus-displayed enterovirus 71 VP1 antigen.A safety study of inactivated Enterovirus 71 vaccine.Experimental infection of tree shrews (Tupaia belangeri) with Coxsackie virus A16.
P2860
Q26866091-3405262E-0941-4481-BEF8-E5714719F595Q27010349-F1BCCBB2-28EB-46D1-A265-E0E4AED2F25DQ31056961-EFF1D234-ECEC-47F2-B360-5A9E49DDD454Q33579809-CC59EFFE-5343-414D-A76F-BD9C07DEB555Q33643774-B5FAA0C4-D3E1-485B-9AC4-D556454CAEDCQ33685512-E339DE05-79BD-4F22-8FF7-91A8869FFC43Q33723474-379729A4-92D6-4E94-B0E6-235CC62F311CQ34033933-4EE5A2A9-6B1F-403D-9BA0-51A2B23E8DEAQ34149853-F8C19EB8-1336-445B-9994-FC5A8933228AQ34430681-D0C986EB-713C-437A-8BDA-1F3F1CE3C6E1Q34571186-EF7D7F11-26C5-4D82-BD75-5B4318B6F296Q35053266-045BD019-872F-4874-9FEB-30B86481ECC1Q35779269-80D04A95-E1FE-4CC6-AF2E-5172EED3401EQ36248450-FAAE3587-821B-43BF-B15E-0D35735133A1Q36363771-40EFAA7C-7B33-41A2-962E-D5049A73F2C3Q36496385-869BC9E2-CD5F-48A7-926C-C1EAAE640411Q36997650-EB0C64B0-B3DB-467E-8D51-C2BEE2021654Q37157420-D63B010E-1E1F-439E-AC78-65FAD3678448Q37530094-CE95F7B2-ED92-4B4D-87D1-FDD180EDBA21Q37681184-C30A83B0-9AA4-48AC-A769-5B0BB87EACE6Q37716692-C95C7942-D9B1-4254-84C3-726330B02703Q38068107-22A5D7E4-9035-4FB2-AC23-E15DE852DC93Q38195326-C2D72961-9528-423D-B078-5EE81218C152Q38225695-E1B20291-67DF-4FCE-9001-97E2E6EB641BQ38840182-83B9F31B-2178-4EEE-BAB4-15814EE0DA1EQ40047717-47AC94A1-0787-4CD7-BCB9-F8F7079B0934Q40087779-2C269F62-0CB7-411D-A68F-309EBE7FC806Q40153226-B51251EE-D7A0-4D8B-8CBB-7D8B9C8C535AQ40178767-8C4BD7FC-401C-4F88-A70F-3BB4EAB2C386Q43434704-B3769F09-5B5F-4F5A-8E07-14BB9664AC81Q46825689-404F0C4B-A554-486B-AA26-B947611ED08FQ51786378-D3B24FAB-7FBC-4BB4-BC6B-B6DE1B0AAB7A
P2860
Immunoprotection elicited by an enterovirus type 71 experimental inactivated vaccine in mice and rhesus monkeys.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Immunoprotection elicited by a ...... ne in mice and rhesus monkeys.
@en
Immunoprotection elicited by a ...... ne in mice and rhesus monkeys.
@nl
type
label
Immunoprotection elicited by a ...... ne in mice and rhesus monkeys.
@en
Immunoprotection elicited by a ...... ne in mice and rhesus monkeys.
@nl
prefLabel
Immunoprotection elicited by a ...... ne in mice and rhesus monkeys.
@en
Immunoprotection elicited by a ...... ne in mice and rhesus monkeys.
@nl
P2093
P1433
P1476
Immunoprotection elicited by a ...... ne in mice and rhesus monkeys.
@en
P2093
Chenghong Dong
Hongling Zhao
Jingjing Wang
Lichun Wang
Longding Liu
Ruixiong Na
Xuemei Zhang
P304
P356
10.1016/J.VACCINE.2011.06.044
P407
P577
2011-06-29T00:00:00Z